Home Newsfeeds Goldman Sachs Downgrades Parkland to Sell

Goldman Sachs Downgrades Parkland to Sell

Goldman Sachs analyst Neil Mehta downgrades Parkland (TSX:PKI) from Neutral to Sell.

byBenzinga Newsdesk

July 13, 2022

1 minute read

Goldman Sachs analyst Neil Mehta downgrades Parkland (TSX:PKI) from Neutral to Sell.

A Look Into Automatic Data Processing Inc’s Price Over Earnings

By Benzinga Insights

March 29, 1:30 PM

In the current market session, Automatic Data Processing Inc. (NASDAQ:ADP) price is at $218.61, after a 2.08% spike.…

ADP

News

Corsair Announces Support For Nvidia’s RTX 4080 Super, RTX 4070 Ti Super, And RTX 4070 Super Graphics Cards With Its Latest Power Supply Ranges

By Benzinga Newsdesk

January 8, 1:05 PM

Corsair Gaming, Inc. (NASDAQ:CRSR) ("Corsair" or the "Company"), a leading global provider and innovator of high-performance gear for gamers, streamers, content-creators, and gaming PC builders, today announces full

CRSR

Elon Musk Says Sam Bankman-Fried Probably Gave Over $1B To Democrats: ‘The Money Went Somewhere’

By Shivdeep Dhaliwal

December 4, 11:19 PM

Twitter CEO Elon Musk said FTX founder Sam Bankman-Fried’s donations in support of Democrats’ election&nb

$FTT

Events
News

AstraZeneca Announced Imfinzi and Tremelimumab With Chemotherapy Demonstrated Sustained Survival Benefit in Metastatic Non-small Cell Lung Cancer, Nearly Doubling the Number of Patients Alive After Three Years vs Chemotherapy

By Charles Gross

September 11, 8:39 AM

Exploratory analysis from POSEIDON Phase III trial also showed trends for overall survival benefit with a limited course of tremelimumab added to Imfinzi and chemotherapy in subgroups with high unmet need

AZN

Goldman Sachs Downgrades Parkland to Sell

Related Posts

A Look Into Automatic Data Processing Inc’s Price Over Earnings

Corsair Announces Support For Nvidia’s RTX 4080 Super, RTX 4070 Ti Super, And RTX 4070 Super Graphics Cards With Its Latest Power Supply Ranges

Elon Musk Says Sam Bankman-Fried Probably Gave Over $1B To Democrats: ‘The Money Went Somewhere’

AstraZeneca Announced Imfinzi and Tremelimumab With Chemotherapy Demonstrated Sustained Survival Benefit in Metastatic Non-small Cell Lung Cancer, Nearly Doubling the Number of Patients Alive After Three Years vs Chemotherapy